Blood or marrow?
- 8 April 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 355 (9211), 1199-1200
- https://doi.org/10.1016/s0140-6736(00)02080-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de MoelleJournal of Clinical Oncology, 2000
- The Risk of Residual Molecular and Cytogenetic Disease in Patients With Philadelphia-Chromosome Positive First Chronic Phase Chronic Myelogenous Leukemia Is Reduced After Transplantation of Allogeneic Peripheral Blood Stem Cells Compared With Bone MarrowBlood, 1999
- A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignanciesBone Marrow Transplantation, 1998
- Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control studyBone Marrow Transplantation, 1998
- Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 1998
- Allogeneic Peripheral Blood Stem Cell Transplantation May Be Associated With a High Risk of Chronic Graft-Versus-Host DiseaseBlood, 1997
- Allogeneic peripheral blood stem cell transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD riskBone Marrow Transplantation, 1997